Sera Prognostics (NASDAQ:SERA) Stock, Quote.Headers.trade-ideas

Sera Prognostics

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Stock_Whisper_Index_Logo_6-copy

Exclusives

Trading Ideas

SCHD

SERA

The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the past week and a look at the reasons why and what&#39;s next.

Benzinga&#39;s &#39;Stock Whisper&#39; Index: 5 Stocks Investors Secretly Monitor But Don&#39;t Talk About Yet

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

ADIL

AGEN

ALLR

ANET

APLD

BENF

CISS

CMAX

CPNG

DXYZ

EZGO

FRGE

GATO

GCTS

HRYU

HUBC

INTZ

LOVE

LXEH

LYEL

MGRM

MNDR

MOGU

MOTS

MRIN

NKLA

NRIX

NXPL

PXMD

RENT

RLYB

SAVA

SBFM

VERU

VIAO

Shares of  JPMorgan Chase &amp; Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

AEHR

ALVO

CHWY

CRML

IVVD

LPRO

RGEN

TRAK

VMEO

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics Inc

Serabi Gold PLC

Offerings

Press Releases

Sera Prognostics Announces Proposed Public Offering

Sera Prognostics Announces Pricing of $50 Million Public Offering

Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025

Earnings

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025

SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER

SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE

EXAS

QTRX

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Anixa Biosciences

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Cabaletta Bio

Coherus BioSciences

Climb Bio

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Caribou Biosciences

CervoMed

Elicio Therapeutics

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Genelux

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

HilleVax

Immunic

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Invivyd

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

OncoCyte

Senti Biosciences

Tenaya Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

XBiotech

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Citigroup

Oppenheimer

Comments

Sera Prognostics

Sera Prognostics (NASDAQ:SERA) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell